Article
Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival.
Leukemia & lymphoma - 1 Sept 2009
Paul Esbjörn, Paul Esbjörn, Uggla Bertil, Deneberg Stefan, Bengtzen Sofia, Hermansson Monica, Dahlman Ingrid, Rosenquist Richard, Wiman Klas G, Nahi Hareth
Abstract excerpt
The p14ARF protein activates the p53 tumor suppressor by binding to and inhibiting its negative regulator HDM-2. We have studied the prognostic impact of p14ARF in acute myeloid leukemia (AML). Leukemic cells from 57 adult patients with normal karyotype de novo AML were analyzed for p14ARF mRNA expression level using real-time polymerase chain reaction (RT-PCR). We also tested the effect of conventional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
